A case of 17-beta-hydroxysteroid dehydrogenase deficiency type 3 in adult endocrinologist practice
17β-Hydroxysteroid dehydrogenase 3 deficiency (17HSD3) is a rare autosomal recessive cause of 46, XY disorders of sex development resulting from HSD17B3 gene mutations, in which conversion of androstenedione to testosterone is impared. The clinical signs of 17HSD3 deficiency depend on the residual a...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2023-05-01
|
Series: | Ожирение и метаболизм |
Subjects: | |
Online Access: | https://www.omet-endojournals.ru/jour/article/view/12999 |
_version_ | 1797204545311342592 |
---|---|
author | N. V. Molashenko N. Yu. Kalinchenko V. A. Ioutsi O. S. Gurinovich D. M. Babaeva A. A. Voznesenskaya N. M. Platonova M. Yu. Yukina A. A. Kolodkina T. A. Ponomareva |
author_facet | N. V. Molashenko N. Yu. Kalinchenko V. A. Ioutsi O. S. Gurinovich D. M. Babaeva A. A. Voznesenskaya N. M. Platonova M. Yu. Yukina A. A. Kolodkina T. A. Ponomareva |
author_sort | N. V. Molashenko |
collection | DOAJ |
description | 17β-Hydroxysteroid dehydrogenase 3 deficiency (17HSD3) is a rare autosomal recessive cause of 46, XY disorders of sex development resulting from HSD17B3 gene mutations, in which conversion of androstenedione to testosterone is impared. The clinical signs of 17HSD3 deficiency depend on the residual activity of the enzyme. The diagnosis of 17HSD3 deficiency is based on reduced testosterone/androstenedione ratio (T/AD < 0.8). Patients are usually assigned at birth and raise as female. If the diagnosis is made before puberty, gonadectomy is recommended, taking into account the risk of masculinization during the puberty and estrogen therapy initiation in this period. If the diagnosis of 17HSD3 deficiency is established during puberty, when virilization manifests, the therapeutic strategy is based on the results of comprehensive psychological testing and gender identity of a patient. In patients with more pronounced masculinization or diagnosis established shortly after birth, who are assigned at birth and raise as male, testosterone therapy is used to achieve a male phenotype. The 17HSD3 deficiency and virilization often result in a change of gender identity during puberty. The article presents a clinical case of 17-βhydroxysteroid dehydrogenase type 3 deficiency with late diagnosis due to parental will. The diagnostic approaches and management of the disease are also described. |
first_indexed | 2024-03-08T09:12:24Z |
format | Article |
id | doaj.art-9943d6f6e4f944f4b670ce9657dd76d4 |
institution | Directory Open Access Journal |
issn | 2071-8713 2306-5524 |
language | English |
last_indexed | 2024-04-24T08:36:56Z |
publishDate | 2023-05-01 |
publisher | Endocrinology Research Centre |
record_format | Article |
series | Ожирение и метаболизм |
spelling | doaj.art-9943d6f6e4f944f4b670ce9657dd76d42024-04-16T16:16:14ZengEndocrinology Research CentreОжирение и метаболизм2071-87132306-55242023-05-01201738310.14341/omet1294210967A case of 17-beta-hydroxysteroid dehydrogenase deficiency type 3 in adult endocrinologist practiceN. V. Molashenko0N. Yu. Kalinchenko1V. A. Ioutsi2O. S. Gurinovich3D. M. Babaeva4A. A. Voznesenskaya5N. M. Platonova6M. Yu. Yukina7A. A. Kolodkina8T. A. Ponomareva9Endocrinology Research CentreEndocrinology Research CentreEndocrinology Research CentreEndocrinology Research CentreEndocrinology Research CentreEndocrinology Research CentreEndocrinology Research CentreEndocrinology Research CentreEndocrinology Research CentreEndocrinology Research Centre17β-Hydroxysteroid dehydrogenase 3 deficiency (17HSD3) is a rare autosomal recessive cause of 46, XY disorders of sex development resulting from HSD17B3 gene mutations, in which conversion of androstenedione to testosterone is impared. The clinical signs of 17HSD3 deficiency depend on the residual activity of the enzyme. The diagnosis of 17HSD3 deficiency is based on reduced testosterone/androstenedione ratio (T/AD < 0.8). Patients are usually assigned at birth and raise as female. If the diagnosis is made before puberty, gonadectomy is recommended, taking into account the risk of masculinization during the puberty and estrogen therapy initiation in this period. If the diagnosis of 17HSD3 deficiency is established during puberty, when virilization manifests, the therapeutic strategy is based on the results of comprehensive psychological testing and gender identity of a patient. In patients with more pronounced masculinization or diagnosis established shortly after birth, who are assigned at birth and raise as male, testosterone therapy is used to achieve a male phenotype. The 17HSD3 deficiency and virilization often result in a change of gender identity during puberty. The article presents a clinical case of 17-βhydroxysteroid dehydrogenase type 3 deficiency with late diagnosis due to parental will. The diagnostic approaches and management of the disease are also described.https://www.omet-endojournals.ru/jour/article/view/1299917β-hydroxysteroid dehydrogenase type 3 deficiencyandrostenedionedisorders of sex development |
spellingShingle | N. V. Molashenko N. Yu. Kalinchenko V. A. Ioutsi O. S. Gurinovich D. M. Babaeva A. A. Voznesenskaya N. M. Platonova M. Yu. Yukina A. A. Kolodkina T. A. Ponomareva A case of 17-beta-hydroxysteroid dehydrogenase deficiency type 3 in adult endocrinologist practice Ожирение и метаболизм 17β-hydroxysteroid dehydrogenase type 3 deficiency androstenedione disorders of sex development |
title | A case of 17-beta-hydroxysteroid dehydrogenase deficiency type 3 in adult endocrinologist practice |
title_full | A case of 17-beta-hydroxysteroid dehydrogenase deficiency type 3 in adult endocrinologist practice |
title_fullStr | A case of 17-beta-hydroxysteroid dehydrogenase deficiency type 3 in adult endocrinologist practice |
title_full_unstemmed | A case of 17-beta-hydroxysteroid dehydrogenase deficiency type 3 in adult endocrinologist practice |
title_short | A case of 17-beta-hydroxysteroid dehydrogenase deficiency type 3 in adult endocrinologist practice |
title_sort | case of 17 beta hydroxysteroid dehydrogenase deficiency type 3 in adult endocrinologist practice |
topic | 17β-hydroxysteroid dehydrogenase type 3 deficiency androstenedione disorders of sex development |
url | https://www.omet-endojournals.ru/jour/article/view/12999 |
work_keys_str_mv | AT nvmolashenko acaseof17betahydroxysteroiddehydrogenasedeficiencytype3inadultendocrinologistpractice AT nyukalinchenko acaseof17betahydroxysteroiddehydrogenasedeficiencytype3inadultendocrinologistpractice AT vaioutsi acaseof17betahydroxysteroiddehydrogenasedeficiencytype3inadultendocrinologistpractice AT osgurinovich acaseof17betahydroxysteroiddehydrogenasedeficiencytype3inadultendocrinologistpractice AT dmbabaeva acaseof17betahydroxysteroiddehydrogenasedeficiencytype3inadultendocrinologistpractice AT aavoznesenskaya acaseof17betahydroxysteroiddehydrogenasedeficiencytype3inadultendocrinologistpractice AT nmplatonova acaseof17betahydroxysteroiddehydrogenasedeficiencytype3inadultendocrinologistpractice AT myuyukina acaseof17betahydroxysteroiddehydrogenasedeficiencytype3inadultendocrinologistpractice AT aakolodkina acaseof17betahydroxysteroiddehydrogenasedeficiencytype3inadultendocrinologistpractice AT taponomareva acaseof17betahydroxysteroiddehydrogenasedeficiencytype3inadultendocrinologistpractice AT nvmolashenko caseof17betahydroxysteroiddehydrogenasedeficiencytype3inadultendocrinologistpractice AT nyukalinchenko caseof17betahydroxysteroiddehydrogenasedeficiencytype3inadultendocrinologistpractice AT vaioutsi caseof17betahydroxysteroiddehydrogenasedeficiencytype3inadultendocrinologistpractice AT osgurinovich caseof17betahydroxysteroiddehydrogenasedeficiencytype3inadultendocrinologistpractice AT dmbabaeva caseof17betahydroxysteroiddehydrogenasedeficiencytype3inadultendocrinologistpractice AT aavoznesenskaya caseof17betahydroxysteroiddehydrogenasedeficiencytype3inadultendocrinologistpractice AT nmplatonova caseof17betahydroxysteroiddehydrogenasedeficiencytype3inadultendocrinologistpractice AT myuyukina caseof17betahydroxysteroiddehydrogenasedeficiencytype3inadultendocrinologistpractice AT aakolodkina caseof17betahydroxysteroiddehydrogenasedeficiencytype3inadultendocrinologistpractice AT taponomareva caseof17betahydroxysteroiddehydrogenasedeficiencytype3inadultendocrinologistpractice |